The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lapatinib combined with ECF/x as first-line metastatic gastric cancer (GC) according to HER2 and EGFR status: A randomized placebo controlled phase II (EORTC 40071).
 
Markus Hermann Moehler
No Relationships to Disclose
 
Arno Schad
No Relationships to Disclose
 
Murielle E. Mauer
No Relationships to Disclose
 
Carlo G. M. Messina
No Relationships to Disclose
 
Jestinah. M. Mahachie John
No Relationships to Disclose
 
Istvan Lang
No Relationships to Disclose
 
Eric Van Cutsem
Research Funding - Amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
João Freire
No Relationships to Disclose
 
Manfred P. Lutz
No Relationships to Disclose
 
Arnaud Roth
No Relationships to Disclose